HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bert Vander Cruyssen Selected Research

Bert Vander Cruyssen Research Topics

Disease

16Rheumatoid Arthritis
01/2022 - 01/2005
3Inflammation (Inflammations)
12/2019 - 02/2008
3Ankylosing Spondylitis
07/2013 - 08/2007
2Osteoarthritis
12/2018 - 06/2012
2Arthritis (Polyarthritis)
12/2012 - 08/2007
2Experimental Arthritis
02/2008 - 08/2007
1Communicable Diseases (Infectious Diseases)
12/2019
1Spondylarthropathies
01/2019
1Pain (Aches)
12/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Joint Diseases (Joint Disease)
03/2017
1Psoriatic Arthritis
06/2012
1Disease Progression
06/2012
1Thrombocytopenia (Thrombopenia)
07/2011
1Necrosis
08/2007

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
01/2022 - 01/2006
5Rheumatoid FactorIBA
01/2022 - 01/2006
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
4Peptides (Polypeptides)IBA
01/2022 - 01/2006
3Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2007
3Antirheumatic Agents (DMARD)IBA
03/2017 - 10/2007
3Methotrexate (Mexate)FDA LinkGeneric
03/2017 - 01/2010
3Infliximab (Remicade)FDA Link
01/2010 - 01/2005
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2019 - 01/2019
2C-Reactive ProteinIBA
03/2017 - 06/2011
2GlucocorticoidsIBA
03/2017 - 04/2015
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2012 - 08/2007
2HLA-B27 Antigen (HLA B27 Antigen)IBA
12/2012 - 06/2011
2LigandsIBA
02/2008 - 08/2007
2EpitopesIBA
10/2007 - 03/2007
1Immunoglobulin A (IgA)IBA
01/2022
1Edetic Acid (EDTA)FDA Link
12/2019
1Etanercept (Enbrel)FDA Link
12/2018
1cyclic citrullinated peptideIBA
01/2018
1Biological ProductsIBA
01/2016
1SteroidsIBA
12/2012
14-hexyloxyaniline (HOA)IBA
06/2012
1Adalimumab (Humira)FDA Link
06/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012
1Heparin (Liquaemin)FDA LinkGeneric
07/2011
1Rituximab (Mabthera)FDA Link
01/2010
1PhytochemicalsIBA
02/2008
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
02/2008
1CytokinesIBA
08/2007
1C-galactosylceramideIBA
08/2007
1alpha-galactosylceramideIBA
08/2007
1Pharmaceutical PreparationsIBA
08/2007
1AntigensIBA
03/2007
1Fibrinogen (Factor I)FDA Link
01/2006
1acetyl 4-aminosalicylic acidIBA
01/2006

Therapy/Procedure

6Therapeutics
06/2011 - 01/2005
3Intravenous Infusions
01/2010 - 01/2005
1Remission Induction
03/2017
1Biological Therapy
01/2016
1Hip Replacement Arthroplasty (Total Hip Replacement)
07/2013
1Retreatment
01/2010